D
Denali
DNLIHealth Care· South San Francisco, California, USA
LAYOFFS TRACKED
1
LAST EVENT
Jun 2, 2025
MARKET CAP
$3.93B
as of Aug 26, 2026
EMPLOYEES
200
Denali Therapeutics is a biotechnology company focused on developing therapies for neurodegenerative diseases. The company aims to harness its proprietary technology platform to discover and develop innovative treatments for conditions such as Alzheimer's disease and Parkinson's disease.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Denali Therapeutics yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Denali Therapeutics
We'll email you the moment a new layoff is reported here.